MicrobiologybioRxiv
A recombinant selective drug-resistant M. bovis BCG enhances the bactericidal activity of a second-line tuberculosis regimen
G. Chiwala, Z. Liu, J. N. Mugweru…·T. Zhang
This study develops a drug-resistant recombinant BCG vaccine that enhances second-line TB treatment efficacy in a murine model of drug-resistant tuberculosis.
DOI 10.1016/j.biopha.2021.112047